8-K
filed October 3, 2025, 7:59 PM ET
ticker MCRB
CIK 0001609809
other material
confidence high
sentiment negative
materiality 0.65
Seres Therapeutics cuts workforce 25%, extends cash runway into Q2 2026
Seres Therapeutics, Inc.
- Reducing workforce by approximately 25%, including reductions effective August 2025.
- Expected cash charges of $1.0-1.4 million, primarily severance, paid in Q4 2025.
- Cash runway extended into Q2 2026 based on current operating plans and cost savings.
- Company cites need to reduce costs to advance strategic priorities amid ongoing losses.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-25-230118
- form_type
- 8-K
- ticker
- MCRB
- cik
- 0001609809
- company_name
- Seres Therapeutics, Inc.
- filed_at
- 2025-10-03T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:39.913116+00:00
- generated_at
- 2026-05-17T04:45:11.630138+00:00
- sec_items
- ["8.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-25-230118
- json_url
- https://secwatch.observer/filing/0001193125-25-230118.json
- markdown_url
- https://secwatch.observer/filing/0001193125-25-230118.md
- text_url
- https://secwatch.observer/filing/0001193125-25-230118.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1609809/000119312525230118/0001193125-25-230118-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1609809/000119312525230118/d63317d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
KPEA
Kun Peng International announces 1-for-10 reverse stock split effective June 2, 2026
Kun Peng International Ltd.
June 1, 2026, 5:30 PM ET
other_material
Items 3.03, 8.01, 5.03
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
KRMN
Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds
Karman Holdings Inc.
June 1, 2026, 5:28 PM ET
other_material
Items 1.01, 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
GIPR
Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit
GENERATION INCOME PROPERTIES, INC.
June 1, 2026, 5:27 PM ET
other_material
Items 1.01, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
PECE
Peace Acquisition Corp closes IPO of 6M units at $10.00/unit, raising $60M
Peace Acquisition Corp.
June 1, 2026, 5:16 PM ET
other_material
Items 3.02, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
MUX
McEwen receives $49.4M dividend from Minera Santa Cruz; total 2026 dividends now $58.2M
McEwen Inc.
June 1, 2026, 5:14 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
MVIS
MicroVision seeks reverse stock split approval; ratio 1:5 to 1:15; annual meeting July 10, 2026
MICROVISION, INC.
June 1, 2026, 5:02 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
STEP
StepStone completes third exchange, now owns 65% of three asset class entities
StepStone Group Inc.
June 1, 2026, 4:55 PM ET
other_material
Items 3.02, 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
IMRX
Immuneering reports 17.3-month median OS in Phase 2a pancreatic trial of atebimetinib
Immuneering Corp
June 1, 2026, 4:51 PM ET
other_material
Items 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.